Completed PHASE4 INTERVENTIONAL 2-arm NCT01626560

The Effects of Daptomycin and Cytokines Production in Comparison With Vancomycin

Effects of Daptomycin in the Levels of IL-1, IL-6 and TNF in Patients With Complicated Cellulitis/Erisipela in Comparison With Vancomycin or Oxacillin

Sponsor: Hospital Universitario Evangelico de Curitiba

Conditions Cellulitis

Interventions Daptomycin Vancomycin

Updated 5 times since 2017 Last updated: Mar 19, 2015 Started: Jul 31, 2012 Primary completion: Mar 31, 2015 Completion: Mar 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01626560, this PHASE4 trial focuses on Cellulitis and remains completed. Sponsored by Hospital Universitario Evangelico de Curitiba, it has been updated 5 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jul 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Universitario Evangelico de Curitiba

Data source: Hospital Universitario Evangelico de Curitiba

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Curitiba, Brazil